Ventilator Acquired Pneumonia Clinical Trial
Official title:
Cost Effectiveness Of Linezolid Vs Vancomycin In The Treatment Of Ventilator Acquired Pneumonia In Central America
The therapy with Linezolid (LIN) represents better cost-effectiveness vs. Vancomycin (VAN) for the treatment of nosocomial Pneumonia associate to ventilator (VAP).
n/a
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05487586 -
Real-World Study of Ceftazidime Avibactam in China
|
||
Completed |
NCT01770015 -
Bronchial Colonization With Fungi and Late Respiratory Acquired Pneumonia
|
N/A | |
Completed |
NCT00332982 -
Ontario ICU Clinical Best Practices Demonstration Project
|
N/A | |
Completed |
NCT01807884 -
Comparison of Two Strategies of Oropharyngeal and Tracheal Suctioning in Mechanically Ventilated Patients
|
N/A | |
Completed |
NCT00938002 -
Study to Determine Quicker Methods of Diagnosing Pneumonia Caused by a Breathing Machine in Critically Ill Patients
|
||
Completed |
NCT01042353 -
Direct E-test on Bronchoalveolar Lavage From Patients With Ventilator-acquired Pneumonia
|
Phase 4 |